
### [NCIT:C3616](http://purl.obolibrary.org/obo/NCIT_C3616)
**Label:** Benign Renal Pelvis Neoplasm

**Subclasses:** [NCIT:C4528](http://purl.obolibrary.org/obo/NCIT_C4528) (Renal Pelvis Urothelial Papilloma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 39.52%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 39.52%


